USAID Launches Anti-Theft System After Medical Supply Scandals in Kenya

USAID Launches Anti-Theft System After Medical Supply Scandals in Kenya

2026-04-29 services

Nairobi, 29 April 2026
Following systematic theft of HIV test kits and essential medical equipment through Kenya’s state-run medical authority, USAID has deployed a revolutionary tracking system to prevent health supplies from reaching black markets. The initiative comes after investigators uncovered significant vulnerabilities in a $650 million award programme, where life-saving medications meant for vulnerable populations including refugees were diverted from public distribution channels.

New Partnership Targets Global Supply Chain Vulnerabilities

The USAID Office of Inspector General signed a memorandum of understanding on Monday, 28 April 2026, with the National Association of Boards of Pharmacy to create a sophisticated detection system for diverted health commodities [1]. This partnership leverages technology to improve visibility and oversight across pharmaceutical supply chains, specifically targeting the misuse or theft of U.S.-funded global health commodities worldwide [1]. Sean Bottary, the OIG’s acting assistant inspector general for investigations, emphasised that the system will strengthen investigations into diversion, fraud, and other risks by flagging medications that appear in unauthorised locations [1].

Focus on Global Health Supply Chain Project

For the initial six-month period, the tracking system will concentrate on monitoring the U.S. government’s Global Health Supply Chain project, an initiative whose future remains under debate [1]. The system represents a significant technological advancement in combating the systematic theft that has plagued international health aid programmes. The timing of this launch coincides with heightened scrutiny over Kenya’s role in managing U.S.-funded health supplies, following documented cases of widespread diversion through state-run distribution channels.

Kenya Medical Supplies Authority Under Scrutiny

Previous OIG investigations revealed significant vulnerabilities in the Kenya Medical Supplies Authority’s core business processes during a $650 million USAID award programme [2]. These systemic weaknesses in KEMSA’s capacity to warehouse and distribute U.S.-funded health commodities have prompted urgent warnings to the Department of State [2]. The state-run corporation, which operates under Kenya’s Ministry of Health, has been designated to handle procurement, warehousing, and distribution under a newly announced bilateral health cooperation framework [2].

Billion-Dollar Framework Raises Concerns

On 4 December 2025, the U.S. Department of State and the Republic of Kenya announced a $2.5 billion bilateral health cooperation framework establishing a government-to-government partnership for detecting, preventing, and responding to infectious disease threats [2]. However, this substantial investment has raised immediate concerns given KEMSA’s proposed central role in the programme [2]. The OIG has specifically alerted the Department of State to the previously identified vulnerabilities in KEMSA’s operational capacity, highlighting the systemic risks associated with government-to-government awards, particularly in the global health sector [2].

Bronnen


medical supplies KEMSA